Luke Watson
Overview
Explore the profile of Luke Watson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watson L, Pope T, Jay R, Banerjee A, Wernet P, Penfold T
Struct Dyn
. 2023 Nov;
10(6):064101.
PMID: 37941993
Accurate computations of experimental observables are essential for interpreting the high information content held within x-ray spectra. However, for complicated systems this can be difficult, a challenge compounded when dynamics...
2.
Watson L, Rankine C, Penfold T
Phys Chem Chem Phys
. 2022 Apr;
24(16):9156-9167.
PMID: 35393987
X-ray absorption spectroscopy at the L edge can be used to obtain detailed information about the local electronic and geometric structure of transition metal complexes. By virtue of the dipole...
3.
Theile H, Wiper J, Noblet T, Watson L, Wagels M
ANZ J Surg
. 2022 Feb;
92(5):1190-1195.
PMID: 35180330
Background: Soft tissue lower limb reconstruction often requires free tissue transfer. We investigated whether the target vessels used for micro-vascular anastomosis in the lower limb influences microsurgical outcomes. Methods: Data...
4.
Fazekas B, Alagesan S, Watson L, Ng O, Conroy C, Catala C, et al.
Stem Cell Rev Rep
. 2022 Jan;
18(4):1444-1460.
PMID: 35013938
Mesenchymal stromal cells (MSCs) ameliorate pre-clinical sepsis and sepsis-associated acute kidney injury (SA-AKI) but clinical trials of single-dose MSCs have not indicated robust efficacy. This study investigated immunomodulatory effects of...
5.
Watson L, Hovav O, Phua Y
J Craniofac Surg
. 2021 Oct;
32(7):e680-e682.
PMID: 34705374
Focal thinning of the calvarial bones unrelated to an underlying systemic disease is uncommon. Of such cases documented in the medical literature, most are bilateral parietal bone thinning, which tends...
6.
Targeting stromal cell Syndecan-2 reduces breast tumour growth, metastasis and limits immune evasion
Loftus P, Watson L, Deedigan L, Camarillo-Retamosa E, Dwyer R, OFlynn L, et al.
Int J Cancer
. 2020 Nov;
148(5):1245-1259.
PMID: 33152121
Tumour stromal cells support tumourigenesis. We report that Syndecan-2 (SDC2) is expressed on a nonepithelial, nonhaematopoietic, nonendothelial stromal cell population within breast cancer tissue. In vitro, syndecan-2 modulated TGFβ signalling...
7.
Lynch K, Treacy O, Chen X, Murphy N, Lohan P, Islam M, et al.
Mol Ther
. 2020 Jun;
28(9):2023-2043.
PMID: 32531237
Mesenchymal stromal cells (MSCs) are a promising therapeutic option for multiple immune diseases/disorders; however, efficacy of MSC treatments can vary significantly. We present a novel licensing strategy to improve the...
8.
Watson L, Chen X, Ryan A, Fleming A, Carbin A, OFlynn L, et al.
Cells
. 2020 Jun;
9(6).
PMID: 32503335
Individuals living with type 1 diabetes mellitus may experience an increased risk of long bone fracture. These fractures are often slow to heal, resulting in delayed reunion or non-union. It...
9.
Watson L, Dunn D, Fraser-Kirk G
Aesthetic Plast Surg
. 2017 Oct;
42(2):447-450.
PMID: 29026955
Level Of Evidence V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the...
10.
Rooney P, Srivastava A, Watson L, Quinlan L, Pandit A
Acta Biomater
. 2015 Mar;
19:66-75.
PMID: 25818949
Hyaluronic acid (HA) has received a lot of attention recently as a biomaterial with applications in wound healing, drug delivery, vascular repair and cell and/or gene delivery. Interstitial cystitis (IC)...